30 results
8-K
EX-99.2
TRML
Tourmaline Bio Inc
24 Jan 24
Results of Operations and Financial Condition
5:10pm
product candidates, if approved, by patients, the medical community and third-party payors;
evolving standards of care in target indications
424B3
2rgjmar0o8x30yt
15 Sep 23
Prospectus supplement
6:31am
S-4/A
n28e7t371b
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
h1h9u1e43ou2xm nde
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
i5wc18te bn65
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
chfhx504pske3tobod65
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
ckyyehe67krwbnc5
30 Jun 22
Other Events
4:54pm